Herbidus Formulations Private Limited, a active private limited company, was established on 15 September 2020 in Delhi, Delhi, India. Engaging in tobacco products & alternatives within the trade sector, it holds CIN: U24232DL2020PTC369976. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.11 M.
Its leadership includes Rajpal Singh (Additional Director), Mahesh Chand (Director), Deepak Kumar Jena (Director). Past directors included Harshal Goel. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 12/22, Sf, Gali No. 2 East Patel Nagar, Delhi, Delhi, 110008.
U24232DL2020PTC369976
369976
15 September 2020
₹1.00 M
₹0.11 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Herbidus Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajpal Singh | Additional Director | 28 Aug 2023 | Current |
| Mahesh Chand | Director | 11 Aug 2022 | Current |
| Deepak Kumar Jena | Director | 15 Sep 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Aug 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Herbidus Formulations Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 24.09% decrease. The company also saw a substantial improvement in profitability, with a 48.94% increase in profit. The company's net worth observed a substantial decline by a decrease of 1807.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Herbidus Formulations had a public holding of 5.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Herbidus Formulations has a workforce of 0 employees as of Nov 13, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Herbidus Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herbidus Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Herbidus Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Herbidus Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
Rajpal Singh was appointed as a Additional Director was appointed as a Additional Director on 28 Aug 2023 & has been associated with this company since 2 years 3 months . was recorded as a recent event.
Progress on Mahesh Chand was appointed as a Director was appointed as a Director on 11 Aug 2022 & has been associated with this company since 3 years 3 months . was documented.
Progress on Deepak Kumar Jena was appointed as a Director was appointed as a Director on 15 Sep 2020 & has been associated with this company since 5 years 2 months . was documented.
Progress on Herbidus Formulations Private Limited was registered on 15 Sep 2020 with Roc Delhi & aged 5 years 2 months as per MCA records. was documented.
The CIN of Herbidus Formulations Private Limited is U24232DL2020PTC369976.
Herbidus Formulations Private Limited is headquartered at 12/22, Sf, Gali No. 2 East Patel Nagar, Delhi, Delhi, 110008.
Herbidus Formulations Private Limited was incorporated on 15 September 2020.
The current directors of Herbidus Formulations Private Limited are
The primary industry of Herbidus Formulations Private Limited is Trade.
Herbidus Formulations Private Limited is unlisted.
The authorized capital of Herbidus Formulations Private Limited is ₹1.00 M, and the paid-up capital is ₹0.11 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX